Also trades as: ASBP (NASDAQ) · $vol 6M
ASBPW NASDAQ
Aspire Biopharma Holdings, Inc.
1W: -9.1%
1M: -1.6%
3M: +25.9%
YTD: -3.2%
1Y: -52.0%
$0.02
+0.00 (+35.34%)
Weekly Expected Move ±57.1%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
23 relationships23
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-07-19
Earliest Filing
2025-11-14
Latest Filing
target: 10
acquirer: 7
investor: 6
Counterparties (Filed by ASBPW)
23 relationshipsCompanies named in ASBPW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ARENA BUSINESS SOLUTIONS GLOBAL SPC II, LTD | AREN | investor | Investor purchasing up to $100 million of common stock from the Company | 2025-11-14 | View |
| ASPIRE BIOPHARMA HOLDINGS, INC. | ASBPW | target | Company issuing and selling common stock to the Investor | 2025-11-14 | View |
| Aspire Biopharma Holdings, Inc. | ASBPW | target | Company entering settlement agreement to cure default and extend loan maturities | 2025-04-30 | View |
| Aspire Biopharma Holdings, Inc. | ASBPW | target | Company issuing securities in a private placement offering | 2025-02-21 | View |
| ARENA BUSINESS SOLUTIONS GLOBAL SPC II, LTD | AREN | investor | Investor purchasing up to $100 million of common stock from the Company | 2025-02-20 | View |
| POWERUP ACQUISITION CORP | PWUP | target | Company issuing and selling common stock to the Investor | 2025-02-20 | View |
| Blackstone Capital Advisors, Inc. | BX | investor | Subscriber purchasing 10% Promissory Notes and Commitment Shares from PowerUp Acquisition Corp. | 2024-12-26 | View |
| Visiox Pharmaceuticals, Inc. | — | target | Target of a terminated business combination and recipient of a bridge loan. | 2024-10-04 | View |
| Aspire Biopharma, Inc. | ASBPW | target | Target of a subsequent business combination agreement. | 2024-10-04 | View |
| PowerUp Acquisition Corp. | — | acquirer | Acquirer in the merger transaction | 2024-09-06 | View |
| PowerUp Merger Sub II, Inc. | — | acquirer | Merger subsidiary of PowerUp Acquisition Corp. | 2024-09-06 | View |
| Srirama Associates, LLC | — | investor | Sponsor of the transaction | 2024-09-06 | View |
| Aspire Biopharma, Inc. | ASBPW | target | Target company in the merger transaction | 2024-09-06 | View |
| PowerUp Acquisition Corp. | — | acquirer | SPAC acquiring Aspire Biopharma in a merger transaction. | 2024-08-30 | View |
| PowerUp Merger Sub II, Inc. | — | acquirer | Wholly owned subsidiary of PowerUp Acquisition Corp. used as the merger vehicle. | 2024-08-30 | View |
| SRIRAMA Associates, LLC | — | investor | Sponsor and Purchaser Representative providing working capital loans. | 2024-08-30 | View |
| Aspire Biopharma, Inc. | ASBPW | target | Biopharmaceutical company being acquired in the merger. | 2024-08-30 | View |
| PowerUp Acquisition Corp. | — | acquirer | Acquirer in the merger agreement | 2024-06-07 | View |
| PowerUp Merger Sub Inc. | — | acquirer | Merger subsidiary of PowerUp Acquisition Corp. | 2024-06-07 | View |
| Srirama Associates, LLC | — | investor | Sponsor of the transaction | 2024-06-07 | View |
| Visiox Pharmaceuticals, Inc. | — | target | Target company in the merger agreement | 2024-06-07 | View |
| SRIRAMA Associates, LLC | — | acquirer | Acquirer purchasing shares and warrants from the Sponsor | 2023-07-19 | View |
| PowerUp Sponsor LLC | — | target | Selling Class A Ordinary Shares and private placement warrants to the Acquirer | 2023-07-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-29 | Accountant Change; Exhibits | View | |
| 2026-09-09 | Bylaws Amendment; Other Events; Exhibits | View | |
| 2026-09-08 | Regulation FD; Exhibits | View | |
| 2026-08-19 | Regulation FD; Exhibits | View | |
| 2026-08-10 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-07-20 | Other Events | View | |
| 2026-06-22 | Shareholder Vote | View | |
| 2026-06-12 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-12 | Other Events | View | |
| 2026-04-20 | Regulation FD; Exhibits | View | |
| 2026-04-17 | Material Agreement; Bylaws Amendment; Exhibits | Agreement | View |
| 2026-04-16 | Regulation FD; Exhibits | View | |
| 2026-04-16 | Shareholder Vote | View | |
| 2026-04-16 | Material Agreement; Bylaws Amendment; Exhibits | Agreement | View |
| 2026-04-15 | Material Agreement | Agreement | View |
| 2026-02-12 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure/Electio | Agreement | View |
| 2026-02-06 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2026-01-30 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2026-01-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-13 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR